A Study Testing the Safety and Effectiveness of Antibodies for Treating Early Stages of COVID-19 in Non-hospitalized Patients
This study will test whether a single dose of antibodies can help prevent COVID-19 from getting worse in high-risk adult patients recently diagnosed with COVID-19.
Why this Research Matters
If you have been recently diagnosed with COVID-19, we want to find out if a single dose of antibodies can help prevent your disease from getting worse as compared to a placebo. Antibodies are protective proteins made by the immune system. A placebo is an i
Who can Participate
You may be eligible for the study: if you are at least 55 years old, or at least 18 years old with a weakened immune system; if you have been diagnosed with COVID-19 within the last 5 days; if you have COVID-19 symptoms and they have started within the las You may not be eligible for the study: if you have any condition that increases the risk of blood clots or other serious problems with blood; if you have a history of allergic reactions to blood products or treatments like the one being studied; if you hav
Study ID
Protocol Number: 24-0980
Meet the Team
Principal Investigator